Neurological systemic diseases caused by a diagnosed vitamin B1 and vitamin B6 deficiency.
Unless otherwise prescribed, adults take one tablet per day. In acute cases, the dosage can be increased to one tablet three times a day, after consulting a doctor.
The tablets are best to be taken with sufficient fluid.
After four weeks at the latest, the doctor should decide whether the elevated dosage of vitamin B6 and vitamin B1 (three times one tablet per day) is indicated further. If necessary, the dosage should be adjusted to one tablet per day to reduce the risk of neuropathy associated with vitamin B6 deficiency.
One tablet contains benfotiamine (lipid-soluble derivative of vitamin B1 ) 300 mg, pyridoxine hydrochloride (vitamin B6 ) 100 mg. For other ingredients, please refer to the direction for use.
milgamma® 300 mg Filmtabletten. Active substance: Benfotiamine, pyridoxine hydrochloride (vitamin B6). Therapeutic indications: Neurological systemic diseases caused by a diagnosed vitamin B1 and vitamin B6 deficiency. If you have any questions about risks and side effects, please read the patient information leaflet and ask your doctor or pharmacist. Wörwag Pharma GmbH & Co. KG, 71034 Böblingen
30 film-coated tablets: PZN 02913880
60 film-coated tablets: PZN 02913897
90 film-coated tablets: PZN 02913905